United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - amoxicillin trihydrate; potassium clavulanate - oral tablet - 500mg ; 125mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - amoxicillin trihydrate; potassium clavulanate - oral tablet - 250mg ; 125mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - amoxicillin trihydrate; potassium clavulanate - oral tablet - 500mg ; 125mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - amoxicillin trihydrate; potassium clavulanate - oral tablet - 250mg ; 125mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - amoxicillin trihydrate; potassium clavulanate - oral tablet - 250mg ; 125mg

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - powder for solution for inj/inf - amoxicillin as sodium 500 mg; clavulanic acid as potassium clavulanate 100 mg - amoxicillin and enzyme inhibitor - augmentin is indicated for the treatment of the following infections in adults and children: severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis, and sinusitis when accompanied by severe systemic signs and symptoms), acute exacerbations of chronic bronchitis (adequately diagnosed), community acquired pneumonia. cystitis, pyelonephritis, skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis, bone and joint infections, in particular osteomyelitis, intra-abdominal infections, female genital infections. prophylaxis against infections associated with major surgical procedures in adults, such as those involving the: gastrointestinal tract, pelvic cavity, head and neck, biliary tract surgery..

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - powder for solution for inj/inf - amoxicillin as sodium 1000 mg; clavulanic acid as potassium clavulanate 200 mg - amoxicillin and enzyme inhibitor - augmentin is indicated for the treatment of the following infections in adults and children: severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis, and sinusitis when accompanied by severe systemic signs and symptoms), acute exacerbations of chronic bronchitis (adequately diagnosed), community acquired pneumonia. cystitis, pyelonephritis, skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis, bone and joint infections, in particular osteomyelitis, intra-abdominal infections, female genital infections. prophylaxis against infections associated with major surgical procedures in adults, such as those involving the: gastrointestinal tract, pelvic cavity, head and neck, biliary tract surgery.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

smith_kb -

Ireland - English - HPRA (Health Products Regulatory Authority)

primecrown 2010 ltd - amoxicillin trihydrate, clavulanate potassium - powder for oral suspension - 400/57 mg/5ml - combinations of penicillins, incl. beta-lactamase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - amoxicillin trihydrate; clavulanic acid (in the form of potassium clavulanate) - film-coated tablet - 875/125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor